Home/Filings/4/0001035267-25-000080
4//SEC Filing

Rosa David J. 4

Accession 0001035267-25-000080

CIK 0001035267other

Filed

Mar 5, 7:00 PM ET

Accepted

Mar 6, 4:45 PM ET

Size

14.9 KB

Accession

0001035267-25-000080

Insider Transaction Report

Form 4
Period: 2025-03-05
Rosa David J.
Sr VP Emerging Procedures & Te
Transactions
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2025-03-0514,6250 total
    Exercise: $77.00Exp: 2026-08-15Common Stock (14,625 underlying)
  • Exercise/Conversion

    Common Stock

    2025-03-05$77.00/sh+14,625$1,126,109233,807 total
  • Sale

    Common Stock

    2025-03-05$557.47/sh8,369$4,665,452225,438 total
  • Exercise/Conversion

    Common Stock

    2025-03-05$59.46/sh+14,625$869,635240,063 total
  • Sale

    Common Stock

    2025-03-05$557.58/sh8,140$4,538,691231,923 total
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2025-03-0514,6250 total
    Exercise: $59.46Exp: 2026-02-16Common Stock (14,625 underlying)
Footnotes (5)
  • [F1]These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 4, 2025.
  • [F2]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $554.17 to $567.89 as follows: 1,466 shares sold at $554.17 to $554.79; 2,122 shares sold at $556.44 to $557.39; 1,968 shares sold at $557.51 to $558.35; 2,663 shares sold at $558.58 to $559.38; 100 shares sold at $559.63; and 50 shares sold at $567.89. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  • [F3]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $554.17 to $567.89 as follows: 1,305 shares sold at $554.17 to $554.57; 1,751 shares sold at $556.44 to $557.42; 2,133 shares sold at $557.51 to $558.28; 2,748 shares sold at $558.52 to $559.37; 100 shares sold at $559.63; and 103 shares sold at $567.89. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  • [F4]Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.
  • [F5]Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.

Issuer

INTUITIVE SURGICAL INC

CIK 0001035267

Entity typeother

Related Parties

1
  • filerCIK 0001519593

Filing Metadata

Form type
4
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 4:45 PM ET
Size
14.9 KB